Long-term maintenance of vision required to drive in patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) following anti-VEGF intravitreal therapy (IVT)

被引:0
|
作者
Emami-Naeini, Parisa [1 ]
Boucher, Nicholas [2 ]
Fernando, Rusirini [2 ]
Menezes, Alicia [3 ]
Garmo, Vincent [3 ]
机构
[1] Univ Calif Davis, Ophthalmol, Davis, CA 95616 USA
[2] Vestrum Hlth, Ottawa, ON, Canada
[3] Genentech Inc, San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3516
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Maintenance of Vision Needed to Drive after Intravitreal Anti-VEGF Therapy in Patients with Neovascular Age-related Macular Degeneration and Diabetic Macular Edema
    Emami-Naeini, Parisa
    Garmo, Vincent
    Boucher, Nick
    Fernando, Rusirini
    Menezes, Alicia
    OPHTHALMOLOGY RETINA, 2024, 8 (04): : 388 - 398
  • [2] Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration
    Munk, Marion R.
    Ceklic, Lala
    Ebneter, Andreas
    Huf, Wolfgang
    Wolf, Sebastian
    Zinkernagel, Martin S.
    ACTA OPHTHALMOLOGICA, 2016, 94 (08) : E757 - E764
  • [3] Long-term outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
    Querques, Lea
    Bandello, Francesco
    Corvi, Federico
    La Spina, Carlo
    Benatti, Lucia
    Sarraf, David
    Freund, K. Bailey
    Parodi, Maurizio Battaglia
    Souied, Eric H.
    Querques, Giuseppe
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Long-term effects of anti-VEGF injections on intraocular pressure in patients with age-related macular degeneration and diabetic macular edema
    Williams, Blake
    Nariani, Ashiyana
    Poudyal, Shirish
    Hariprasad, Seenu M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [5] Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema
    Ciulla, Thomas A.
    Hussain, Rehan M.
    Taraborelli, Donna
    Pollack, John S.
    Williams, David F.
    OPHTHALMOLOGY RETINA, 2022, 6 (09): : 796 - 806
  • [6] Switching intravitreal anti-VEGF treatment in neovascular age-related macular degeneration
    Kucukerdonmez, Cem
    Gelisken, Faik
    Yoeruek, Efdal
    Bartz-Schmidt, Karl Ulrich
    Leitritz, Martin Alexander
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (01) : 51 - 56
  • [7] Characterizing Long-term Vision Change and Intravitreal Anti-VEGF Treatment Pattern Among Neovascular Age-Related Macular Degeneration (nAMD) Patients in the US: Analysis of the Vestrum Database
    Truong, Cecile
    Yiu, Glenn
    Chang, Shih-Chen
    Willis, Jeffrey
    Boucher, Nicholas
    Ishii, Fabio
    Asik, Kemal
    Kulkarni, Priya
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [8] Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy
    Bandello, Francesco
    Corvi, Federico
    La Spina, Carlo
    Benatti, Lucia
    Querques, Lea
    Capuano, Vittorio
    Naysan, Jonathan
    Chen, Xuejing
    Sarraf, David
    Parodi, Maurizio Battaglia
    Souied, Eric
    Freund, K. Bailey
    Querques, Giuseppe
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (12) : 1611 - 1616
  • [9] Intravitreal anti-VEGF therapy in neovascular age-related macular degeneration: Bevacizumab versus Ranibizumab
    Zehetner, C.
    Kralinger, M. T.
    Kieselbach, G. F.
    SPEKTRUM DER AUGENHEILKUNDE, 2008, 22 (06) : 370 - 375
  • [10] Third nerve palsy following intravitreal anti-VEGF therapy for bilateral neovascular age-related macular degeneration
    Micieli, Jonathan A.
    Santiago, Patrick
    Brent, Michael H.
    ACTA OPHTHALMOLOGICA, 2011, 89 (01) : E99 - E100